FLT1 and ovarian carcinoma: In addition, for VE-cadherin a comparable significant (p < 0.05) decrease in HUVEC co-cultured with our human ovarian cancer cells was detected, which was prevented by simultaneous treatment with the VEGF-inhibitor Flt1-Fc.